MedTrace Logo

Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes

NCT02910141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 590

Last updated 2017-03-03

No results posted yet for this study

Summary

This study aims to compare glycaemic control during continuous subcutaneous insulin fusion (CSII, insulin pump therapy) and multiple daily insulin injections in type 2 diabetes and to identify patient-level characteristics that predict the best improvement in control and any change in insulin dose or other outcome.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

Continuous subcutaneous insulin infusion

Infusion of short-acting insulin from a portable pump

Sponsors & Collaborators

  • University of Leicester

    collaborator OTHER

  • University Hospital, Caen

    collaborator OTHER

  • King's College London

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-01-31
Completion
2016-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910141 on ClinicalTrials.gov